Astal Laboratories Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Astal Laboratories Ltd is ₹ 82.3 as of 12 May 15:30 . The P/E Ratio of Astal Laboratories Ltd changed from 437.5 on March 2021 to 8.4 on March 2025 . This represents a CAGR of -54.64% over 5 yearsThe P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Astal Laboratories Ltd changed from ₹ 3.47 crore on March 2021 to ₹ 74.72 crore on March 2025 . This represents a CAGR of 84.77% over 5 yearsThe Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 14.94 crore on March 2025 to ₹ 14.94 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Astal Laboratories Ltd for the Dec '25 is ₹ 52.27 crore as compare to the Sep '25 revenue of ₹ 37.55 crore. This represent the growth of 39.2% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 1.62 crore as compare to the Sep '25 revenue of ₹ 1.32 crore. This represent the growth of 22.73% The ebitda of Astal Laboratories Ltd for the Dec '25 is ₹ 3.59 crore as compare to the Sep '25 ebitda of ₹ 3.9 crore. This represent the decline of -7.95% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.05 crore. This represent the decline of -20% The net profit of Astal Laboratories Ltd changed from ₹ 1.69 crore to ₹ 2.36 crore over 7 quarters. This represents a CAGR of 21.02% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.01 crore to ₹ 0.03 crore over 7 quarters. This represents a CAGR of 87.34% The Dividend Payout of Astal Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Astal Laboratories Ltd

Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited.
The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'.
Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024.
The Company is now a subsidiary of Aceso Research Labs LLP. The Company was promoted by the Kanpur based business house of Parasrampurias.
The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc. During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Astal Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Astal Laboratories Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Astal Laboratories Ltd is 362 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 26 Cr

What are the key factors driving the stock performance of Astal Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Astal Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astal Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 12, 2026, the Astal Laboratories Ltd stock price is INR ₹85.98. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹23.02.

How do dividend payouts of Astal Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Astal Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.